
You can purchase shares of T. Rowe Price Health Care ETF (NASDAQ:TMED) through any online brokerage.
There are no as such competitors for T. Rowe Price Health Care ETF.
There is no analysis for T. Rowe Price Health Care ETF to provide a consensus price target.
The stock price for T. Rowe Price Health Care ETF (NASDAQ: TMED) is $33.8094 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for T. Rowe Price Health Care ETF.
T. Rowe Price Health Care ETF does not have any upcoming earnings scheduled.
There is no upcoming split for T. Rowe Price Health Care ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Value |
| Fund Inception | Jun 11, 2025 |
| Managers | Sal Rais |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| LLY | Eli Lilly And Company | 10.9% |
| UNH | United Healthcare Corp... | 5.36% |
| GILD | Gild Gilead Sciences I... | 3.10% |
| TMO | Thermo Fisher | 3.84% |
| ALNY | Alnylam Pharmac.. | 5.73% |
| COR | Cencora Inc Common Sto... | 3.30% |
| PODD | Insulet Corp_None_0 | 3.08% |
| A | Agilent Technologies | 2.86% |
| ELAN | Elanco Animal Health I... | 2.65% |
| CYTK | Cytokinetics Inc | 2.64% |
Benzinga Rankings give you vital metrics on any stock – anytime.